Several lines of research are underway to develop new strategies to increase the NIS expression levels in refractory thyroid cancer cells, but most studies have focused on inducing an upregulation of NIS at the transcriptional level [16,17]. The gene discussed is SLC5A5; the disease is thyroid gland carcinoma.